anmelden
SMI
13.095,87
PKT
-5,46
PKT
-0,04
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SMI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 31.10.19 | UBS Neutral | JP Morgan Chase & Co. | |
| 30.10.19 | Holcim buy | Goldman Sachs Group Inc. | |
| 30.10.19 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 30.10.19 | UBS buy | Goldman Sachs Group Inc. | |
| 30.10.19 | UBS Equal weight | Barclays Capital | |
| 30.10.19 | UBS Neutral | JP Morgan Chase & Co. | |
| 30.10.19 | UBS Equal weight | Barclays Capital | |
| 30.10.19 | UBS Equal-Weight | Morgan Stanley | |
| 30.10.19 | UBS Sector Perform | RBC Capital Markets | |
| 30.10.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 30.10.19 | UBS buy | UBS AG | |
| 30.10.19 | Holcim overweight | JP Morgan Chase & Co. | |
| 29.10.19 | Holcim Equal weight | Barclays Capital | |
| 29.10.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 28.10.19 | Holcim overweight | JP Morgan Chase & Co. | |
| 26.10.19 | UBS Neutral | Goldman Sachs Group Inc. | |
| 25.10.19 | Novartis Underweight | Barclays Capital | |
| 25.10.19 | Holcim Neutral | UBS AG | |
| 24.10.19 | Novartis Neutral | UBS AG | |
| 24.10.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 24.10.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 24.10.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 23.10.19 | UBS Outperform | Credit Suisse Group | |
| 23.10.19 | ABB (Asea Brown Boveri) Equal-Weight | Morgan Stanley | |
| 23.10.19 | Novartis Neutral | Credit Suisse Group | |
| 23.10.19 | Novartis Underweight | Barclays Capital | |
| 23.10.19 | Nestlé overweight | JP Morgan Chase & Co. | |
| 23.10.19 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 23.10.19 | UBS Sector Perform | RBC Capital Markets | |
| 23.10.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 23.10.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 22.10.19 | Roche buy | Deutsche Bank AG | |
| 22.10.19 | Novartis buy | Merrill Lynch & Co., Inc. | |
| 22.10.19 | UBS buy | Merrill Lynch & Co., Inc. | |
| 22.10.19 | Novartis buy | Jefferies & Company Inc. | |
| 22.10.19 | UBS Sector Perform | RBC Capital Markets | |
| 22.10.19 | Novartis Underweight | Morgan Stanley | |
| 22.10.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 22.10.19 | UBS overweight | JP Morgan Chase & Co. | |
| 22.10.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.